MedPath

TEVA-VORICONAZOLE

TEVA-VORICONAZOLE

Approved
DIN Number

02396866

Drug Class

Human

Market Date

Mar 31, 2014

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02396866
AIG Number0150242001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J02AC03 VORICONAZOLE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:14.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

VORICONAZOLEActive
Strength: 50 MG
Monograph: VORICONAZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.